These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 20054613)
1. Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Wagner C; Tillack D; Simonis G; Strasser RH; Weinbrenner C Mol Cell Biochem; 2010 Jun; 339(1-2):135-47. PubMed ID: 20054613 [TBL] [Abstract][Full Text] [Related]
2. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715 [TBL] [Abstract][Full Text] [Related]
3. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. Park SS; Zhao H; Mueller RA; Xu Z J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918 [TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling. Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553 [TBL] [Abstract][Full Text] [Related]
5. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250 [TBL] [Abstract][Full Text] [Related]
6. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats. Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944 [TBL] [Abstract][Full Text] [Related]
7. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK. Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328 [TBL] [Abstract][Full Text] [Related]
8. Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning. Ciocci Pardo A; Scuri S; González Arbeláez LF; Caldiz C; Fantinelli J; Mosca SM Cardiovasc Pathol; 2018; 33():19-26. PubMed ID: 29414428 [TBL] [Abstract][Full Text] [Related]
9. Ischemic postconditioning mediates cardioprotection via PI3K/GSK-3β/β-catenin signaling pathway in ischemic rat myocardium. Wu QL; Shen T; Shao LL; Ma H; Wang JK Shock; 2012 Aug; 38(2):165-9. PubMed ID: 22576003 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotection induced by sevoflurane-delayed post-conditioning is attributable to increased phosphorylation of mitochondrial GSK-3β through the PI3K/Akt survival pathway. Ye Z; Xia P; Cheng ZG; Guo Q J Neurol Sci; 2015 Jan; 348(1-2):216-25. PubMed ID: 25555490 [TBL] [Abstract][Full Text] [Related]
11. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion. Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154 [TBL] [Abstract][Full Text] [Related]
12. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. Park SS; Zhao H; Jang Y; Mueller RA; Xu Z J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852 [TBL] [Abstract][Full Text] [Related]
13. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt. He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503 [TBL] [Abstract][Full Text] [Related]
15. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. Mio Y; Shim YH; Richards E; Bosnjak ZJ; Pagel PS; Bienengraeber M Anesth Analg; 2009 Mar; 108(3):858-66. PubMed ID: 19224794 [TBL] [Abstract][Full Text] [Related]
16. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal. Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545 [TBL] [Abstract][Full Text] [Related]
17. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Hamid SA; Bower HS; Baxter GF Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176 [TBL] [Abstract][Full Text] [Related]
18. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats. Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways. Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531 [TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Yin H; Chao L; Chao J Hypertension; 2004 Jan; 43(1):109-16. PubMed ID: 14662648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]